Xiaoke Wan as a clear dose used in clinical hypoglycemic agents have been widely used, but not for suffering from mild Type 2 diabetes in the elderly recently, Wushan County, Chongqing Municipality with diabetes in the long-term Mr Lai After taking Xiaoke Wan found poor blood sugar control, they themselves will Xiaoke Wan amount of guidance from a doctor before the day four, to 10 a day, the results appear lower blood sugar symptoms.
According to the Third Military Medical University Xinqiao Hospital director Xuzi endocrine-postdoctoral, Xiaoke Wan as a clear dose used in clinical hypoglycemic agents have been widely used, but Xiaoke Wan is Astragalus, to yellow, and trichosanthin Glibenclamide (glibenclamide), composed of components, not pure Chinese medicine formulations, not for suffering from mild Type 2 diabetes in the elderly, especially in patients with type 1 diabetes can not take more Xiaoke Wan hypoglycemic.
Xu Zi-postdoctoral, said some people mistakenly believe that Xiaoke Wan is a traditional Chinese medicine preparations, so arbitrarily increase the dosage, adverse consequences, the most common is caused dizziness or coma.
Xiaoke Wan because of glibenclamide is to lower blood sugar the active ingredients (usually 10 Xiaoke Wan equivalent to a glibenclamide).
And glibenclamide there are many side effects, it will cause low blood sugar reactions.
Renal insufficiency, ketone positive and hepatitis patients can not or should not be used Xiaoke Wan, it will add to the original condition.
Especially for suffering from mild Type 2 diabetes in the elderly, Xiaoke Wan not the preferred drug.
If all of a sudden the elderly eat 5-10 Xiaoke Wan, will suddenly reduce the number of blood glucose, leading to low blood sugar coma.
In addition, type 1 diabetes the pancreas is completely or partially B-cell function has been lost can not produce insulin, and more generally caused by genetic reasons.
Xiaoke Wan containing glibenclamide, a sulfonylurea drug, the drug is the mechanism used to stimulate and pancreatic cells secreting insulin.
The drug only for type 2 diabetes effectively.
Therefore, the islet cells already in the state of failure in patients with type 1 diabetes, and the use of sulfonylurea this need through the liver and kidneys stimulate the metabolism of drugs, liver and kidney will increase the burden of work, if things continue this way may lead to liver and kidney failure.